Salem Investment Counselors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $124K | Sell |
1,576
-74
| -4% | -$5.97K | ﹤0.01% | 468 |
|
|
2026
Q1 | $144K | Buy |
+1,650
| New | +$158K | ﹤0.01% | 423 |
|
|
2025
Q4 | – | Sell |
-1,587
| Closed | -$152K | – | 843 |
|
|
2025
Q3 | $152K | Buy |
1,587
+174
| +12% | +$16K | ﹤0.01% | 398 |
|
|
2025
Q2 | $124K | Sell |
1,413
-112
| -7% | -$9.5K | ﹤0.01% | 421 |
|
|
2025
Q1 | $138K | Buy |
1,525
+422
| +38% | +$37.8K | ﹤0.01% | 398 |
|
|
2024
Q4 | $89K | Sell |
1,103
-227
| -17% | -$19.7K | ﹤0.01% | 477 |
|
|
2024
Q3 | $121K | Sell |
1,330
-194
| -13% | -$16.3K | ﹤0.01% | 429 |
|
|
2024
Q2 | $121K | Sell |
1,524
-447
| -23% | -$36.6K | ﹤0.01% | 420 |
|
|
2024
Q1 | $173K | Sell |
1,971
-43
| -2% | -$3.67K | 0.01% | 379 |
|
|
2023
Q4 | $167K | Buy |
2,014
+366
| +22% | +$27.9K | 0.01% | 371 |
|
|
2023
Q3 | $130K | Sell |
1,648
-30
| -2% | -$2.51K | 0.01% | 386 |
|
|
2023
Q2 | $149K | Sell |
1,678
-460
| -22% | -$39.6K | 0.01% | 365 |
|
|
2023
Q1 | $174K | Buy |
2,138
+635
| +42% | +$51.8K | 0.01% | 357 |
|
|
2022
Q4 | $118K | Sell |
1,503
-365
| -20% | -$29.6K | 0.01% | 390 |
|
|
2022
Q3 | $152K | Buy |
1,868
+507
| +37% | +$45.6K | 0.01% | 340 |
|
|
2022
Q2 | $123K | Sell |
1,361
-495
| -27% | -$50.2K | 0.01% | 386 |
|
|
2022
Q1 | $206K | Sell |
1,856
-244
| -12% | -$25.8K | 0.01% | 340 |
|
|
2021
Q4 | $217K | Buy |
2,100
+107
| +5% | +$12.4K | 0.01% | 361 |
|
|
2021
Q3 | $250K | Hold |
1,993
| – | – | 0.01% | 316 |
|
|
2021
Q2 | $247K | Hold |
1,993
| – | – | 0.01% | 301 |
|
|
2021
Q1 | $235K | Buy |
1,993
+120
| +6% | +$14.1K | 0.01% | 271 |
|
|
2020
Q4 | $219K | Buy |
1,873
+299
| +19% | +$32.9K | 0.01% | 271 |
|
|
2020
Q3 | $164K | Hold |
1,574
| – | – | 0.01% | 259 |
|
|
2020
Q2 | $144K | Hold |
1,574
| – | – | 0.01% | 264 |
|
|
2020
Q1 | $142K | Sell |
1,574
-235
| -13% | -$25K | 0.01% | 255 |
|
|
2019
Q4 | $205K | Buy |
1,809
+980
| +118% | +$108K | 0.02% | 241 |
|
|
2019
Q3 | $90K | Hold |
829
| – | – | 0.01% | 316 |
|
|
2019
Q2 | $81K | Hold |
829
| – | – | 0.01% | 324 |
|
|
2019
Q1 | $82K | Buy |
+829
| New | +$74.2K | 0.01% | 254 |
|
|
2018
Q4 | – | Sell |
-829
| Closed | -$82K | – | 295 |
|
|
2018
Q3 | $82K | Sell |
829
-800
| -49% | -$74K | 0.01% | 254 |
|
|
2018
Q2 | $139K | Buy |
1,629
+400
| +33% | +$33.4K | 0.01% | 216 |
|
|
2018
Q1 | $96K | Sell |
1,229
-250
| -17% | -$20.6K | 0.01% | 231 |
|
|
2017
Q4 | $119K | Sell |
1,479
-635
| -30% | -$50.9K | 0.01% | 232 |
|
|
2017
Q3 | $165K | Hold |
2,114
| – | – | 0.02% | 202 |
|
|
2017
Q2 | $188K | Buy |
2,114
+123
| +6% | +$10.4K | 0.02% | 204 |
|
|
2017
Q1 | $160K | Sell |
1,991
-777
| -28% | -$60.7K | 0.02% | 250 |
|
|
2016
Q4 | $197K | Buy |
+2,768
| New | +$217K | 0.02% | 236 |
|
|
2016
Q3 | – | Sell |
-5,248
| Closed | -$455K | – | 536 |
|
|
2016
Q2 | $455K | Sell |
5,248
-100
| -2% | -$8.09K | 0.05% | 185 |
|
|
2016
Q1 | $401K | Buy |
5,348
+500
| +10% | +$37.7K | 0.05% | 189 |
|
|
2015
Q4 | $373K | Hold |
4,848
| – | – | 0.05% | 198 |
|
|
2015
Q3 | $322K | Sell |
4,848
-600
| -11% | -$44.2K | 0.04% | 207 |
|
|
2015
Q2 | $404K | Hold |
5,448
| – | – | 0.05% | 203 |
|
|
2015
Q1 | $425K | Sell |
5,448
-643
| -11% | -$48.7K | 0.05% | 205 |
|
|
2014
Q4 | $440K | Sell |
6,091
-300
| -5% | -$20.8K | 0.05% | 197 |
|
|
2014
Q3 | $396K | Hold |
6,391
| – | – | 0.05% | 209 |
|
|
2014
Q2 | $407K | Sell |
6,391
-31,450
| -83% | -$1.91M | 0.05% | 209 |
|
|
2014
Q1 | $2.33M | Sell |
37,841
-400
| -1% | -$23.3K | 0.29% | 89 |
|
|
2013
Q4 | $2.19M | Sell |
38,241
-132
| -0.3% | -$7.49K | 0.29% | 89 |
|
|
2013
Q3 | $2.04M | Hold |
38,373
| – | – | 0.28% | 87 |
|
|
2013
Q2 | $1.98M | Buy |
+38,373
| New | +$1.9M | 0.29% | 83 |
|
Other funds holding MDT
Salem Investment Counselors's MDT Position: Q2 2026 in Review
Salem Investment Counselors reduced its Medtronic (MDT) stake by 4.5% in Q2 2026, selling an estimated $5.97K and leaving 1,576 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #468.
Salem Investment Counselors first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.33M in Q1 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Salem Investment Counselors held 1,576 shares of Medtronic worth $124K as of Q2 2026.
- Salem Investment Counselors sold 74 Medtronic shares in Q2 2026, an estimated $5.97K.
- Medtronic made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #468 holding.
- Salem Investment Counselors first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
- Salem Investment Counselors's Medtronic position peaked at $2.33M in Q1 2014.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.